Aehr Stock Soars 22%, Adding $363 Million, After Raising 2027 Revenue Outlook To $150 Million
The chip-testing company swung to a quarterly profit and lifted its fiscal 2027 revenue outlook after record sales.
Aehr Test Systems, which makes equipment that tests and burns in semiconductor chips, soared 21.60% to $62.59 in Tuesday trading as of 10:01 a.m. ET, adding $363 million in market value, after it said Monday that record quarterly sales and a $109.3 million backlog support a higher full-year outlook.
Outlook raised, sales triple
The company said in an 8-K filed Monday that it now expects fiscal 2027 revenue of $150 million, up from a prior range of $130 million to $150 million.
Quarterly sales tripled to a record $33.0 million, and Aehr posted a $7.2 million profit. New orders totaled $46.7 million, lifting the order cushion to $109.3 million as of November 1.
The stock was on pace for its biggest one-day gain since July 21, when it rose 27.9%.
A burn-in specialist's wild year
Burn-in runs chips under heat and electrical stress to catch early failures. Aehr sells wafer-level systems, the FOX family, and package-level systems, the Sonoma, Tahoe and Echo lines. Customers include chipmakers, contract assemblers and test service companies.
The shares entered the session after a 52% fall over the previous month, sitting 65% below their highest close of the past year, set on Aug. 17. They were still up about 155% year to date as of Monday's close, well ahead of the S&P 500's roughly 10% gain.
In its most recent fiscal-year annual report, Aehr showed revenue of $18.8 million in its latest quarter, up 33.7% from a year earlier. The five largest customers made up about 70% of fiscal 2026 net revenues.
Taiwan test cell and AI customer
In August, Aehr announced a $22 million follow-on order from its lead AI processor production customer, which the company cites as support for that customer's continued burn-in capacity expansion.
Aehr's CEO said a pending test cell is expected to be installed in Taiwan in early calendar 2027, with a broader production decision to follow months later.
The Taiwan test cell, expected in early calendar 2027, is the next milestone the CEO named.
Sources
- Why Is AEHR Stock Surging 10% Overnight? — Yahoo Finance
- Aehr stock jumps on beat and raise amid AI demand (AEHR:NASDAQ) | Seeking Alpha — seekingalpha.com
- Why Aehr Test Systems Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket — benzinga.com
- What Aehr Test Systems (AEHR) Said on Its Q1 Earnings Call — Yahoo Finance
- Aehr signals $150M fiscal 2027 revenue outlook with focus on at least 20% non-GAAP net income margin (NASDAQ:AEHR) — seekingalpha.com
- The company's filing (Aehr Test Systems) — SEC filing
- Aehr Test Systems: 3 Key Takeaways for Long-Term Investors — The Motley Fool
- Aehr Test Systems — Form 10-K for the fiscal year ended 2026-05-29 (quarterly results) — SEC EDGAR